Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Clopidogrel is associated with better in-hospital and 30-day outcomes than ticlopidine after coronary stenting

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • L'Allier, P. L.
  • Aronow, H. D.
  • Cura, F. A.
  • Bhatt, D. L.
  • Albirini, A.
  • Schneider, J. P.
  • Topol, Eric
  • Ellis, S. G.

publication date

  • August 2003

journal

  • Canadian Journal of Cardiology  Journal

subject areas

  • Aged
  • Angioplasty, Balloon, Coronary
  • Aspirin
  • Cause of Death
  • Coronary Stenosis
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Hospital Mortality
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction
  • Platelet Aggregation Inhibitors
  • Premedication
  • Product Surveillance, Postmarketing
  • Retrospective Studies
  • Stents
  • Survival Analysis
  • Ticlopidine
  • Treatment Outcome
scroll to property group menus

Research

keywords

  • acetylsalicylic acid
  • angioplasty
  • clopidogrel
  • platelet aggregation inhibitors
  • stents
  • ticlopidine
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0828-282X

PubMed ID

  • 12915931
scroll to property group menus

Additional Document Info

start page

  • 1041

end page

  • 1046

volume

  • 19

issue

  • 9

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support